Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. ORKA
ORKA logo

ORKA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ORKA News

Oruka Therapeutics Executive Sells Shares Amid Stock Surge

Jun 27 2026NASDAQ.COM

Oruka Therapeutics Executive Sells Shares Amid Stock Surge

Jun 27 2026Fool

Oruka Therapeutics Executive Sells $687K in Stock Amid Surge

Jun 27 2026Yahoo Finance

Analysis of Oruka Therapeutics Executive Stock Transaction

Jun 24 2026Fool

Arjun Agarwal Sells Oruka Shares Amid Price Surge

Jun 24 2026NASDAQ.COM

Baron First Principles ETF Underperforms

Jun 22 2026NASDAQ.COM

Shipping Stocks Show Strength, Led by Safe Bulkers

Jun 22 2026NASDAQ.COM

Dambkowski Sells Majority Stake in Oruka Therapeutics

May 31 2026NASDAQ.COM

Oruka Therapeutics Executive Sells Shares Worth $6.19 Million

May 31 2026Fool

Biotech Sector Approaches Critical Phase 2 Milestones

May 28 2026Newsfilter

Oruka Therapeutics Q1 Earnings Beat Expectations

May 13 2026seekingalpha

Avidity Partners Increases Stake in Oruka Therapeutics

May 13 2026Fool

Achieve Life Sciences Appoints Three Senior Executives

May 12 2026Newsfilter

AbbVie's Strong Earnings Amid Competitive Threats

May 11 2026Fool

AbbVie Faces Competition from New Drug Threat

May 11 2026NASDAQ.COM

Latest Developments in the Biotech Sector

Apr 30 2026NASDAQ.COM